Raymond S. Koff, M.D.
Dr. Koff is Professor of Medicine, University of Massachusetts Medical School, and attending physician, University of Massachusetts Memorial Medical Center, Worcester, Massachusetts, USA.
During the last three years, Dr. Koff has received grant/research support from Schering-Plough, GlaxoSmithKline and Roche. He has been a consultant to GlaxoSmithKline and has also served on the Speakers' Bureau for Roche and Schering-Plough.
Estimated time to complete:
Albert Einstein College of Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Albert Einstein College of Medicine is accredited
by the Accreditation Council for Continuing
Medical Education to provide continuing medical
education for physicians.
Upon completion of this Cyberounds®
, you should be able to:
- Describe the rationale for attempts to develop a HCV vaccine
- Discuss the heterogeneity of HCV and likely mechanisms of viral persistence
- Define the obstacles to HCV vaccine development.